top of page

BENPEN benzylpenicillin (as sodium) 3 g and 1.2 g powder for injection vial – extension to 1st Sept

Pro Pharmaceuticals Group (ProPG) advises that due to a shortage of Australian registered BENPEN benzylpenicillin (as sodium) 3g and 1.2g powder for injection vial, AUST R: 10326. ProPG has arranged for an alternative product Benzylpenicillin sodium 1200 mg powder for injection (Genus Pharmaceuticals). The S19A product is registered and marketed in the UK and the supply is authorized under an exemption granted by the TGA under Section 19A of the Therapeutic Goods Act, 1989 until 1st September 2022.


Please note the S19A is for the 1.2G (1200mg) Strength product **

(This is an extension date from previous)


 
 
Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Social Icon
  • Google+ Basic Square

TEL:

1300 077 674 (1300 0 PRO PG)

FAX:

(03) 86790397

AUSTRALIA​      |  GERMANY  |      POLAND

Pro PG and Logo are registered trademarks (EU, UK, Australia) owned by Pro Pharmaceuticals Group © 2025 Pro Pharmaceuticals Group Pty Ltd  |  All Rights Reserved

VAT: NL825524295B01 VAT: PL5263362401 VAT: DE401757398 ABN: 20605457430 

United Nations Global Marketplace (UNGM) Registered Supplier Vendor No. 1092276

bottom of page